Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Naya Biosciences Inc. (INVO:NASDAQ), powered by AI.
Naya Biosciences Inc. is currently trading at $1.49. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Naya Biosciences Inc. on Alpha Lenz.
Naya Biosciences Inc.'s P/E ratio is -0.3.
“Naya Biosciences Inc. trades at a P/E of -0.3 (undervalued) with strong ROE of 18952.5%.”
Ask for details →Naya Biosciences Inc. is an innovative biotechnology company specializing in advanced medical therapies and drug development. Focused on discovering and developing novel treatments for rare and life-threatening conditions, Naya Biosciences plays a critical role in improving patient outcomes across several medical fields. The company's pipeline is composed of therapies targeting genetic disorders, rare diseases, and unmet medical needs, leveraging cutting-edge technologies such as gene editing and precision medicine. With a strong commitment to research and development, Naya Biosciences often collaborates with academic institutions and pharmaceutical partners to accelerate the transition of experimental treatments from bench to bedside. Headquartered in a strategic location to facilitate collaboration and access to research talent, Naya Biosciences is crucial in reshaping the landscape of modern medicine, providing hope for patients worldwide through pioneering therapies that address significant health challenges.
“Naya Biosciences Inc. trades at a P/E of -0.3 (undervalued) with strong ROE of 18952.5%.”
Ask for details →Naya Biosciences Inc. (ticker: INVO) is a company listed on NASDAQ in the Healthcare sector (Medical Devices). It has approximately 25 employees. Market cap is $2M.
The current price is $1.49 with a P/E ratio of -0.29x and P/B of 2.61x.
ROE is 18952.46% and operating margin is -224.04%. Annual revenue is $3M.